Quebec Innovative Materials says 86% of New Salem-Apple River soil-gas samples show thermogenic wet-gas signature
Bitget2026/10/06 13:03Quebec Innovative Materials reported thermogenic wet-gas signatures in 86% of New Salem–Apple River C1–C4 soil-gas samples. Dry-gas signatures accounted for 8.7% of classified samples; 3.4% fell in the condensate-to-oil range; biogenic or mixed totaled about 2%. Results support a conventional gas and helium model tied to the same structural corridor as its Bennett Hill discovery, which returned up to 30% H2. Around 50 line-kilometers of 2D seismic acquisition is under way to image targets beneath the anomaly corridor. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quebec Innovative Materials Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610060900NEWSFILECNPR____20261006_317628_1) on October 06, 2026, and is solely responsible for the information contained therein.
- Quebec Innovative Materials reported thermogenic wet-gas signatures in 86% of New Salem–Apple River C1–C4 soil-gas samples.
- Dry-gas signatures accounted for 8.7% of classified samples; 3.4% fell in the condensate-to-oil range; biogenic or mixed totaled about 2%.
- Results support a conventional gas and helium model tied to the same structural corridor as its Bennett Hill discovery, which returned up to 30% H
2.
- Around 50 line-kilometers of 2D seismic acquisition is under way to image targets beneath the anomaly corridor.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
Crypto prices
More
